vs

Side-by-side financial comparison of Ballard Power Systems Inc. (BLDP) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $17.7M, roughly 1.5× Ballard Power Systems Inc.). Ballard Power Systems Inc. runs the higher net margin — 994.4% vs -10.3%, a 1004.7% gap on every dollar of revenue.

Ballard Power Systems Inc. is a developer and manufacturer of proton exchange membrane (PEM) fuel cell products for markets such as heavy-duty motive, portable power, material handling as well as engineering services. Ballard has designed and shipped over 400 MW of fuel cell products to date.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

BLDP vs NPCE — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.5× larger
NPCE
$26.6M
$17.7M
BLDP
Higher net margin
BLDP
BLDP
1004.7% more per $
BLDP
994.4%
-10.3%
NPCE

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BLDP
BLDP
NPCE
NPCE
Revenue
$17.7M
$26.6M
Net Profit
$176.5M
$-2.7M
Gross Margin
77.4%
Operating Margin
-6.6%
Net Margin
994.4%
-10.3%
Revenue YoY
23.9%
Net Profit YoY
48.0%
EPS (diluted)
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLDP
BLDP
NPCE
NPCE
Q4 25
$26.6M
Q3 25
$17.7M
$27.4M
Q2 25
$23.5M
Q1 25
$22.5M
Q4 24
$21.5M
Q3 24
$-12.3M
$21.1M
Q2 24
$19.3M
Q1 24
$18.1M
Net Profit
BLDP
BLDP
NPCE
NPCE
Q4 25
$-2.7M
Q3 25
$176.5M
$-3.5M
Q2 25
$-8.7M
Q1 25
$-6.6M
Q4 24
$-5.3M
Q3 24
$-5.5M
Q2 24
$-7.5M
Q1 24
$-8.9M
Gross Margin
BLDP
BLDP
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
156.5%
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
BLDP
BLDP
NPCE
NPCE
Q4 25
-6.6%
Q3 25
-9.5%
Q2 25
-29.0%
Q1 25
-22.9%
Q4 24
-17.0%
Q3 24
-20.1%
Q2 24
-32.4%
Q1 24
-41.6%
Net Margin
BLDP
BLDP
NPCE
NPCE
Q4 25
-10.3%
Q3 25
994.4%
-12.8%
Q2 25
-36.8%
Q1 25
-29.3%
Q4 24
-24.5%
Q3 24
-25.9%
Q2 24
-39.0%
Q1 24
-49.2%
EPS (diluted)
BLDP
BLDP
NPCE
NPCE
Q4 25
$-0.08
Q3 25
$-0.11
Q2 25
$-0.26
Q1 25
$-0.21
Q4 24
$-0.16
Q3 24
$-0.19
Q2 24
$-0.26
Q1 24
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLDP
BLDP
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$19.0M
Total Assets
$105.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLDP
BLDP
NPCE
NPCE
Q4 25
$61.1M
Q3 25
$60.0M
Q2 25
$62.1M
Q1 25
$66.3M
Q4 24
$52.8M
Q3 24
$56.8M
Q2 24
$55.5M
Q1 24
$58.9M
Stockholders' Equity
BLDP
BLDP
NPCE
NPCE
Q4 25
$19.0M
Q3 25
$18.5M
Q2 25
$19.4M
Q1 25
$24.3M
Q4 24
$8.0M
Q3 24
$9.8M
Q2 24
$9.9M
Q1 24
$14.3M
Total Assets
BLDP
BLDP
NPCE
NPCE
Q4 25
$105.6M
Q3 25
$107.3M
Q2 25
$106.1M
Q1 25
$110.2M
Q4 24
$94.6M
Q3 24
$96.3M
Q2 24
$94.4M
Q1 24
$98.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLDP
BLDP
NPCE
NPCE
Operating Cash FlowLast quarter
$5.7M
$506.0K
Free Cash FlowOCF − Capex
$409.0K
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
0.03×
TTM Free Cash FlowTrailing 4 quarters
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLDP
BLDP
NPCE
NPCE
Q4 25
$506.0K
Q3 25
$5.7M
$-1.9M
Q2 25
$-2.1M
Q1 25
$-7.5M
Q4 24
$-4.8M
Q3 24
$-6.6M
$-1.7M
Q2 24
$-3.9M
Q1 24
$-7.5M
Free Cash Flow
BLDP
BLDP
NPCE
NPCE
Q4 25
$409.0K
Q3 25
$-2.0M
Q2 25
$-2.3M
Q1 25
$-7.5M
Q4 24
$-4.8M
Q3 24
$-1.8M
Q2 24
$-4.0M
Q1 24
$-7.6M
FCF Margin
BLDP
BLDP
NPCE
NPCE
Q4 25
1.5%
Q3 25
-7.2%
Q2 25
-9.6%
Q1 25
-33.4%
Q4 24
-22.5%
Q3 24
-8.7%
Q2 24
-20.6%
Q1 24
-42.1%
Capex Intensity
BLDP
BLDP
NPCE
NPCE
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.7%
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.5%
Q2 24
0.3%
Q1 24
0.6%
Cash Conversion
BLDP
BLDP
NPCE
NPCE
Q4 25
Q3 25
0.03×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons